FDA Announces New Labeling Guidelines For Longer Acting Painkillers – Forbes

by admin on September 17, 2013


natmonitor.com
FDA Announces New Labeling Guidelines For Longer Acting Painkillers
Forbes
In making these labeling changes, manufacturers of the drugs will also be required to conduct studies regarding the long term effects of the drugs, since data has been lacking regarding the efficacy of such medications to treat chronic non-cancer
As opioid use soars, no evidence of improved treatment of painScience Codex
Sharp Rise in Opioid Drugs Prescribed for Non-Cancer PainScience Daily (press release)
FDA's new labeling guidelines take on prescription drug abuse epidemicFierceHealthcare
RedOrbit -SF Weekly (blog) -Arthritis Today
all 24 news articles »

View full post on chronic pain – Google News

Previous post:

Next post: